摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3α-hydroxydeoxyartemisinin

中文名称
——
中文别名
——
英文名称
3α-hydroxydeoxyartemisinin
英文别名
(1S,2R,4S,5R,8S,9R,12S,13R)-2-hydroxy-1,5,9-trimethyl-11,14,15-trioxatetracyclo[10.2.1.04,13.08,13]pentadecan-10-one
3α-hydroxydeoxyartemisinin化学式
CAS
——
化学式
C15H22O5
mdl
——
分子量
282.337
InChiKey
NTBCVGIABGYJEM-ZPOPJUNVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    20
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.93
  • 拓扑面积:
    65
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    青蒿素 在 Aspergillus niger AS 3.795 作用下, 反应 96.0h, 以15%的产率得到3α-hydroxydeoxyartemisinin
    参考文献:
    名称:
    棘孢坎尼汉菌和黑曲霉对青蒿素的微生物转化
    摘要:
    进行了Cunninghamella echinulata(AS 3.3400)和黑曲霉(AS 3.795)对青蒿素1的微生物转化。获得两种产物,10β-羟基青蒿素2和3α-羟基脱氧青蒿素3。根据化学和光谱数据确定了它们的结构。10β-羟基青蒿素是一种新化合物。
    DOI:
    10.1016/s0040-4039(02)00812-2
点击查看最新优质反应信息

文献信息

  • Unified Mechanistic Framework for the Fe(II)-Induced Cleavage of Qinghaosu and Derivatives/Analogues. The First Spin-Trapping Evidence for the Previously Postulated Secondary C-4 Radical
    作者:Wen-Min Wu、Yikang Wu、Yu-Lin Wu、Zhu-Jun Yao、Cheng-Ming Zhou、Ying Li、Feng Shan
    DOI:10.1021/ja973080o
    日期:1998.4.1
    Qinghaosu and derivatives were easily reduced by ferrous sulfate in aqueous acetonitrile to give results different from those reported for other reducing systems. The unstable epoxide 7, a compound that was postulated earlier as a species responsible for the antimalarial activity, now has been isolated and characterized. The earlier speculative secondary C-4 radical has also been trapped with 2-me
    青蒿素及其衍生物乙腈溶液中很容易被硫酸亚铁还原,结果与其他还原体系报道的结果不同。不稳定的环氧化物 7 是一种较早被假定为具有抗疟活性的物质的化合物,现在已被分离和表征。早期推测的二级 C-4 自由基也被 2-甲基-2-亚硝基丙烷捕获,因此为自由基参与 QHS 型化合物的体外裂解提供了第一个直接证据。对于亚离子诱导的 1,2,4-三恶烷(即 QHS 等)裂解,提出了具有可互换自由基阴离子和可逆分子内自由基反应的统一机制。在此框架的基础上,结合反离子和溶剂效应的考虑,
  • Transition-Metal-Catalyzed Group Transfer Reactions for Selective C−H Bond Functionalization of Artemisinin
    作者:Yungen Liu、Wenbo Xiao、Man-Kin Wong、Chi-Ming Che
    DOI:10.1021/ol071269r
    日期:2007.10.1
    carbenoid and nitrenoid C-H bond insertion reactions. With rhodium complexes as catalysts, lactone 11 was synthesized via carbene insertion reaction at the C16 position in 90% yield; oxazolidinone 13 was synthesized via nitrene insertion reaction at the C10 position in 87% yield based on 77% conversion; and sulfamidate 14 was synthesized via nitrene insertion reaction at the C8 position in 87% yield.
    通过过渡属催化的分子内类胡萝卜素和氮烯基CH键插入反应合成了三种类型的新型青蒿素生物。以配合物为催化剂,通过卡宾插入反应在C16位合成内酯11,收率为90%。恶唑烷酮13是通过在C10位的亚硝基插入反应以77%的转化率以87%的产率合成的;通过C8位的亚硝基插入反应合成了氨基磺酸酯14,产率为87%。
  • Interaction of Qinghaosu (Artemisinin) with Cysteine Sulfhydryl Mediated by Traces of Non-Heme Iron
    作者:Yikang Wu、Zheng-Yu Yue、Yu-Lin Wu
    DOI:10.1002/(sici)1521-3773(19990903)38:17<2580::aid-anie2580>3.0.co;2-j
    日期:1999.9.3
    The antimalarial action of 1,2,4-trioxanes such as qinghaosu (QHS) may take place through the mechanism shown schematically: In the presence of cysteine traces of non-heme iron (FeSO(4)) may cleave the peroxy bond of QHS rapidly, and the transient carbon-centered radical can attack the sulfur ligand to form a covalent bond.
    1,2,4-三恶烷类化合物如青蒿素(QHS)的抗疟作用可能通过示意性机理进行:在半胱酸中存在非血红素(FeSO(4))可能会裂解QHS的过氧键很快,以碳为中心的瞬态自由基会攻击配体以形成共价键。
  • Chemical and electro-chemical reduction of qinghaosu (artemisinin)
    作者:Wen-Min Wu、Yu-Lin Wu
    DOI:10.1039/b007056o
    日期:——
    1,2,4-Trioxane is the essential segment of the new antimalarial agent qinghaosu 1, and hence its reduction is an important plausible process related to the bio-activity mode. An overview of its reduction and a careful examination of some reducing systems are presented herewith. Electrochemical reduction is a two-electron reduction, which is confirmed by the isolation of product deoxyqinghaosu. However, in the presence of a catalytic amount of FeII/III electrochemical reduction yields mainly the single-electron-reduction products, which are identified with the products from reduction of qinghaosu with one equivalent ferrous sulfate or a catalytical amount of FeII/III and excess of other reducing agents, such as ascorbic acid, or cysteine. These results mean that qinghaosu is reduced by ferrous ion and the resulting ferric ion is then reduced on the electrode to regenerate ferrous ion. In addition, qinghaosu could be reduced to deoxyqinghao by iodide, but not by bromide, and also could be reduced by the ascorbic acid–CuSO4 system to give free-radical reaction products.
    1,2,4-三恶烷是新型抗疟药青蒿素1的重要组成部分,因此其还原是与生物活性模式相关的重要合理过程。本文介绍了其还原的概述以及对一些还原系统的仔细检查。电化学还原是双电子还原,通过产物脱氧青蒿素的分离证实了这一点。然而,在催化量的 FeII/III 存在下,电化学还原主要产生单电子还原产物,这与用一当量硫酸亚铁或催化量的 FeII/III 和过量硫酸亚铁还原青蒿素的产物相同。其他还原剂,例如抗坏血酸或半胱酸。这些结果意味着青蒿素被亚离子还原,然后生成的离子在电极上被还原以再生亚离子。此外,青蒿素可以被化物还原为脱氧青蒿,但不能被化物还原,也可以被抗坏血酸-CuSO4体系还原,得到自由基反应产物。
  • A possible antimalarial action mode of qinghaosu (artemisinin) series compounds. Alkylation of reduced glutathione by C-centered primary radicals produced from antimalarial compound qinghaosu and 12-(2,4-dimethoxyphenyl)-12-deoxoqinghaosu
    作者:Dong-Ye Wang、Yu-Lin Wu
    DOI:10.1039/b006906j
    日期:——
    Antimalarial compound qinghaosu (1) and its phenyl derivative 2 were reacted with reduced glutathione (GSH) and Fe(II/III) to give, besides other known degradation products, an interesting adduct from a primary C-centered free radical and GSH. Because GSH plays a very important role in the cell cycle, this finding may eventually lead to a new understading of its mode of action.
    抗疟化合物青蒿素 (1) 及其苯基衍生物 2 与还原型谷胱甘肽 (GSH) 和 Fe(II/III) 反应,除了其他已知的降解产物外,还生成了一种有趣的以 C 为中心的自由基和 GSH 的加合物。由于 GSH 在细胞周期中起着非常重要的作用,这一发现可能最终导致对其作用方式的新认识。
查看更多

同类化合物

苄基二亚苄基-α-D-甘露吡喃糖苷 苄基2-C-甲基-3,4-O-(1-甲基亚乙基)-BETA-D-吡喃核糖苷 艾日布林中间体,艾瑞布林中间体 艾日布林中间体 脱氧青蒿素 甲基6-脱氧-3,4-O-异亚丙基-beta-L-甘油-吡喃己糖苷 甲基3,4-异亚丙基-beta-L-阿拉伯糖吡喃糖苷 甲基3,4-O-异亚丙基-beta-L-赤式-吡喃戊-2-酮糖 甲基3,4-O-(氧代亚甲基)-beta-D-吡喃半乳糖苷 甲基2-O-甲基-3,4-O-(1-甲基乙亚基)-alpha-D-吡喃半乳糖苷 甲基 外-2,3:4,6-二-O-亚苄基-alpha-D-吡喃甘露糖苷 甲基 3,4-O-异亚丙基吡喃戊糖苷 甲基 3,4-O-异亚丙基-alpha-D-吡喃半乳糖苷 甲基 2,3-O-羰基-4,6-O-异亚丙基-alpha-D-吡喃甘露糖苷 果糖二丙酮氯磺酸酯 果糖二丙酮 托吡酯杂质8 托吡酯杂质7 托吡酯杂质6 托吡酯N-甲基杂质 托吡酯-d12 托吡酯-13C6 托吡酯 吡啶,2,3-二氯-5-(二氟甲基)- 史氏环氧化恶唑烷酮甲基催化剂 双丙酮半乳糖 双丙酮-L-阿拉伯糖 六氢二螺[环己烷-1,2'-[1,3]二氧杂环戊并[4,5]吡喃并[3,2-d][1,3]二恶英-8',1''-环己烷]-4'-醇 二(表脱氧二氢青蒿素)醚 乙酰胺,N-(3,4,5,6,7,8-六氢-2-吖辛因基)-N-甲基- b-D-半乳吡喃糖,1,6-二脱氧-1,6-环硫-3,4-O-(1-甲基亚乙基)-(9CI) [(3aS,5aR,7R,8aR,8bS)-7-(羟基甲基)-2,2,7-三甲基四氢-3aH-二[1,3]二氧杂环戊并[4,5-b:4',5'-d]吡喃-3a-基]甲基氨基磺酸 D-半乳醛环3,4-碳酸 6-脱氧-6-碘-1,2:3,4-二-o-异亚丙基-α-d-半乳糖吡喃糖苷 6-脱氧-6-N-辛基氨基-1,2-3,4-二-O-异亚丙基-alpha-D-吡喃半乳糖 6-叠氮基-6-脱氧-1,2:3,4-二-o-异亚丙基-d-半乳糖吡喃糖苷 6-O-乙酰基-1,2:3,4-二-O-异亚丙基-alpha-D-吡喃半乳糖 4,6-二邻乙酰基-2,3-邻羰基-alpha-D-吡喃甘露糖酰溴 4,5-O-(1-甲基乙亚基)-beta-D-吡喃果糖 3alpha-羟基去氧基蒿甲醚 3-羟基去oxydihydroartemisinin 3,5,11-三氧杂-10-氮杂三环[6.2.1.02,6]十一碳-2(6),7,9-三烯 3,4-O-异亚丙基-L-阿拉伯糖 3,4-O-(苯基亚甲基)-D-核糖酸 D-内酯 3,4,6-三-O-苄基-beta-D-吡喃甘露糖-1,2-(甲基原乙酸酯) 3,4,6-三-O-乙酰基-alpha-D-吡喃葡萄糖1,2-(乙基原乙酸酯) 3,4,6-三-O-乙酰基-Alpha-D-吡喃半乳糖-1,2-(甲基原乙酸酯) 3,4,6-三-O-乙酰基-1,2-O-亚乙基吡喃己糖 2,6-脱水-5-脱氧-3,4-O-(氧代亚甲基)-1-O-(三异丙基硅烷基)-D-阿拉伯糖-己-5-烯糖 2,3:4,6-二-o-异亚丙基-d-甘露糖苷甲酯